Marks, L. J., Ritter, V., Agrusa, J., Kamdar, K. Y., Rivers, J., Gardner, R. A., Ehrhardt, M. J., Devine, K. J., Phillips, C. A., Reilly, A. F., August, K., Weinstein, J. L., Satwani, P., Forlenza, C. J., Smith, C. M., Greer, C., Afify, Z., Lin, C. H., Belsky, J. A., … Aftandilian, C. (2025). Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014745

Kinslow, C. J., Kim, A., Rohde, C. H., Sanchez, G. I., Yu, J. B., Kim, D. K., Lowe, L. S., Kachnic, L. A., Cheng, S. K., Crew, K. D., Neugut, A. I., & Horowitz, D. P. (2024). Systematic under-ascertainment of anaplastic large cell lymphoma cases in cancer registries: report from a comprehensive cancer center. Journal of Plastic, Reconstructive & Aesthetic Surgery, 95, 49–51. https://doi.org/10.1016/j.bjps.2024.05.058

Ku, A., & Alobeid, B. (2023). IRF4/DUSP22-positive anaplastic large cell lymphoma arising in the setting of chronic olecranon bursitis. Blood, 141(23), 2912–2912. https://doi.org/10.1182/blood.2023019992

Kinslow, C. J., DeStephano, D. M., Rohde, C. H., Kachnic, L. A., Cheng, S. K., Neugut, A. I., & Horowitz, D. P. (2022). Risk of Anaplastic Large Cell Lymphoma Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Ductal Carcinoma in Situ. JAMA Network Open, 5(11), e2243396. https://doi.org/10.1001/jamanetworkopen.2022.43396

Savage, K. J., Horwitz, S. M., Advani, R., Christensen, J. H., Domingo-Domenech, E., Rossi, G., Morschhauser, F., Alpdogan, O., Suh, C., Tobinai, K., Shustov, A., Trneny, M., Yuen, S., Zinzani, P. L., Trümper, L., Ilidge, T., O’Connor, O. A., Pro, B., Miao, H., … Iyer, S. (2022). Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood Advances, 6(19), 5550–5555. https://doi.org/10.1182/bloodadvances.2020003971

Kinslow, C. J., Kim, A., Sanchez, G. I., Cheng, S. K., Kachnic, L. A., Neugut, A. I., & Horowitz, D. P. (2022). Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018. JAMA Oncology, 8(9), 1354. https://doi.org/10.1001/jamaoncol.2022.2624